Market Place
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain. 
X
Please Wait
Applying Filters...
01 Egis Pharmaceuticals PLC (1)
02 EUROAPI FRANCE (1)
03 Sanofi chimie (1)
04 Cadila Healthcare Limited (1)
05 Catalent Micron Technologies, Inc. (1)
06 Emcure Pharmaceuticals Limited (1)
07 Fagron Inc (1)
08 Fagron Services BV (1)
09 Ipca Laboratories Limited (1)
10 KALCHEM INTERNATIONAL INC (1)
11 Medisca Inc. (1)
12 PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (1)
13 Professional Compounding Centers of America dba PCCA (1)
14 Sigma-Aldrich Ireland Ltd. (1)
01 PROMETHAZINE (1)
02 PROMETHAZINE HYDROCHLORIDE (5)
03 Promethazine Hcl (1)
04 Promethazine Hydrochloride (6)
05 Promethazine hydrochloride (1)
01 France (2)
02 Hungary (1)
03 India (3)
04 Netherlands (2)
05 U.S.A (4)
06 United Kingdom (2)
RDD 2024
Not Confirmed
Contact Supplier
32
PharmaCompass offers a list of Promethazine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Promethazine Hydrochloride manufacturer or Promethazine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Promethazine Hydrochloride manufacturer or Promethazine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Promethazine Hydrochloride API Price utilized in the formulation of products. Promethazine Hydrochloride API Price is not always fixed or binding as the Promethazine Hydrochloride Price is obtained through a variety of data sources. The Promethazine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride, including repackagers and relabelers. The FDA regulates 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride supplier is an individual or a company that provides 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride active pharmaceutical ingredient (API) or 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride finished formulations upon request. The 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride suppliers may include 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride suppliers with NDC on PharmaCompass.
We have 12 companies offering 1-phenothiazin-10-yl-N,N-bis(trideuteriomethyl)propan-2-amine;hydrochloride
Get in contact with the supplier of your choice:
